These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 10794060)
1. T-cell memory: lessons from Epstein-Barr virus infection in man. Rickinson AB; Callan MF; Annels NE Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):391-400. PubMed ID: 10794060 [TBL] [Abstract][Full Text] [Related]
2. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus. Rickinson AB Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264 [No Abstract] [Full Text] [Related]
3. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients. Strang G; Rickinson AB Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228 [TBL] [Abstract][Full Text] [Related]
4. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH; Wolf H; Minarovits J Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410 [TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Rickinson AB; Moss DJ Annu Rev Immunol; 1997; 15():405-31. PubMed ID: 9143694 [TBL] [Abstract][Full Text] [Related]
7. The immunology of Epstein-Barr virus infection. Moss DJ; Burrows SR; Silins SL; Misko I; Khanna R Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):475-88. PubMed ID: 11313006 [TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value of Epstein-Barr virus diagnosis]. Bauer G Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107 [No Abstract] [Full Text] [Related]
9. The biology of Epstein-Barr virus: lessons learned from the virus and the host. Cohen JI Curr Opin Immunol; 1999 Aug; 11(4):365-70. PubMed ID: 10448133 [TBL] [Abstract][Full Text] [Related]
11. Manipulation of the immune response by Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus: consequences for tumor development. Ressing ME; Wiertz EJ Semin Cancer Biol; 2008 Dec; 18(6):379-80. PubMed ID: 18992819 [No Abstract] [Full Text] [Related]
13. Risk factors for visceral leishmaniasis: role of Epstein-Barr virus infection. Louzir H; Triki H; Bennani S; Edelman L; Laouini D; Ben Ismail R; Joab I; Dellagi K Arch Inst Pasteur Tunis; 1993; 70(3-4):357-62. PubMed ID: 7802490 [No Abstract] [Full Text] [Related]
14. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire. D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615 [TBL] [Abstract][Full Text] [Related]
17. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study. Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus infection in infants and their mothers. Simon MW Am Fam Physician; 1997 Aug; 56(2):380, 382. PubMed ID: 9262520 [No Abstract] [Full Text] [Related]
19. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus. Delecluse HJ; Feederle R; Behrends U; Mautner J Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248 [TBL] [Abstract][Full Text] [Related]
20. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients. Klein G; Purtilo D Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974 [No Abstract] [Full Text] [Related] [Next] [New Search]